Moore Capital Management, LP Global Blood Therapeutics, Inc. Transaction History

Moore Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$22.3 - $37.39 $434,872 - $729,142	-19,501 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $500,785 - $694,040	19,501 New	19,501 $676,000
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $3.38 Million - $4.42 Million	-86,915 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $934,849 - $1.58 Million	-24,830 Reduced 22.22%	86,915 $3.76 Million
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $5.9 Million - $8.32 Million	111,745 New	111,745 $6.16 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.